Literature DB >> 11304594

Nylon versus polydioxanone in the correction of rectus diastasis.

F X Nahas1, S M Augusto, C Ghelfond.   

Abstract

Nylon and polydioxanone are two sutures commonly used to correct rectus diastasis. Polydioxanone, as an absorbable suture, has the advantage of not being palpable in thin patients. Because several forces act against the plication, an absorbable suture would not be efficient in these cases. In this study, two groups of 10 patients each were studied. These patients underwent abdominoplasty and correction of rectus diastasis. In the control group, 2-0 nylon was used to plicate the anterior aponeurosis and 0-polydioxanone was used in the experimental group. The tension of the abdominal wall was measured with a dynamometer in both groups. The width of rectus diastasis was measured 3 cm above and 2 cm below the umbilicus, using a computed tomography (CT) scan before the operation and 3 weeks and 6 months after surgery. The width of rectus diastasis was measured intraoperatively at the same levels. The data were analyzed by Student's t test. Both groups had similar abdominal wall tension on both levels. The diastasis recti was completely corrected at both levels, as confirmed by the 3-week postoperative CT scan and the 6-month CT scan. At the superior level, the width of the rectus diastasis on the preoperative CT scan (2.6 +/- 0.7 cm) was similar to the values obtained intraoperatively (2.7 +/- 0.6 cm), showing no significant statistical difference. At the inferior level, the largest difference between the preoperative CT scan and the intraoperative finding was 0.3 cm. In conclusion, the correction of rectus diastasis with 2-0 nylon and 0-polydioxanone was achieved and maintained after 6 months. CT scans are an accurate method for studying rectus diastasis and other muscles of the abdominal wall.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304594     DOI: 10.1097/00006534-200103000-00008

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  9 in total

1.  Pseudotumors after primary abdominal lipectomy as a new sequela in patients with abdominal apron.

Authors:  Adrian Dragu; Alexander D Bach; Elias Polykandriotis; Ulrich Kneser; Raymund E Horch
Journal:  Obes Surg       Date:  2008-06-11       Impact factor: 4.129

2.  Non-traumatic hernia of the lateral abdominal wall in a patient infected with the human immunodeficiency virus.

Authors:  Z Fan; J Pan; X Liu; C Zhuang; J Ren; H Yu; S Tang; S Wang
Journal:  Ann R Coll Surg Engl       Date:  2016-05-31       Impact factor: 1.891

Review 3.  A systematic review on the outcomes of correction of diastasis of the recti.

Authors:  F Hickey; J G Finch; A Khanna
Journal:  Hernia       Date:  2011-06-18       Impact factor: 4.739

4.  Prevalence of diastasis recti abdominis in a urogynecological patient population.

Authors:  Theresa M Spitznagle; Fah Che Leong; Linda R Van Dillen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

Review 5.  Open Versus Laparoscopic Surgical Management of Rectus Diastasis: Systematic Review and Pooled Analysis of Complications and Recurrence Rates.

Authors:  Hassan ElHawary; Christian Chartier; Peter Alam; Jeffrey E Janis
Journal:  World J Surg       Date:  2022-04-16       Impact factor: 3.282

Review 6.  Management Strategies for Diastasis Recti.

Authors:  Maurice Y Nahabedian
Journal:  Semin Plast Surg       Date:  2018-07-24       Impact factor: 2.314

Review 7.  Treatment Options for Abdominal Rectus Diastasis.

Authors:  Majken Lyhne Jessen; Stina Öberg; Jacob Rosenberg
Journal:  Front Surg       Date:  2019-11-19

8.  Umbilical Port Site Hernia and Diastasis Recti.

Authors:  Hyun Jeong Ki; Jun Beom Park; Ji-Young Sul
Journal:  J Minim Invasive Surg       Date:  2020-06-15

9.  Long-term follow-up after surgical repair of abdominal rectus diastasis: A Prospective Randomized Study.

Authors:  Ebba Swedenhammar; Karin Strigård; Peter Emanuelsson; Ulf Gunnarsson; Birgit Stark
Journal:  Scand J Surg       Date:  2020-04-17       Impact factor: 2.360

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.